Qlucore to Expand its Marketing Efforts with New High-profile Appointment to its Board
News Nov 25, 2009
Qlucore has appointed Pia Gideon, the former Vice President of Marketing and Communication at Ericsson, to its Board of Directors.
“Qlucore is now ready for the next phase of expansion, and we are thrilled to have Pia Gideon joining us, as we know that Qlucore will benefit from her extensive experience in global marketing and communications,” says Cecilia Schelin Seidegård, Chairman of the Board.
Qlucore is best known for its highly intuitive Qlucore Omics Explorer product, which enables instant analysis and adds increased creativity to research, thanks to the software's impressive speed and statistical capability. Qlucore was founded in 2007 and has already delivered its solutions to leading research organisations and pharmaceutical companies all over the world.
Qlucore is a privately-owned company in which the founders and management hold a substantial portion of the shares. The company has today confirmed that it has raised 1,3 MSEK (approx. £115,000) in fresh capital which will be used to intensify its sales and marketing efforts.
Sanchi Oil Spill Contamination Could Take Three Months to Reach MainlandNews
Water contaminated by the oil currently leaking into the ocean from the Sanchi tanker collision is likely to take at least three months to reach land, and if it does the Korean coast is the most likely location. However, the oil’s fate is highly uncertain, as it may burn, evaporate, or mix into the surface ocean and contaminate the environment for an extended duration.READ MORE
Blue Brain Nexus: An Open-Source Tool for Data-Driven ScienceNews
The Blue Brain Nexus will help enable data-driven science through searching, integrating and tracking large-scale data and models.READ MORE
Researchers Identify Druggable Genomic Targets in Malaria ParasiteNews
Using whole-genome analysis and chemogenomics, scientists have discovered novel antimalarial drug targets and drug-resistance genes. The researchers analyzed >250 Plasmodium falciparum cell lines, which were resistant to 37 different anti-malarial compounds.READ MORE